CDCP1 Identifies a Broad Spectrum of Normal and Malignant Stem/Progenitor Cell Subsets of Hematopoietic and Nonhematopoietic Origin-Reference-Cited by-同舟云学术

CDCP1 Identifies a Broad Spectrum of Normal and Malignant Stem/Progenitor Cell Subsets of Hematopoietic and Nonhematopoietic Origin

Published:2004-05 Issue:3 Volume:22 Page:334-343
ISSN:1066-5099
Container-title:STEM CELLS
language:en
Short-container-title:STEM CELLS

Author:

Bühring Hans‐Jörg¹,Kuçi Selim²,Conze Tim¹,Rathke Gisa¹,Bartolović Kerol¹,Grünebach Frank¹,Scherl‐Mostageer Marwa³,Brümmendorf Tim H.¹,Schweifer Norbert³,Lammers Reiner⁴

Affiliation:

1. University of Tübingen, Department of Internal Medicine II, Division of Hematology, Immunology, Oncology and Rheumatology, Tübingen, Germany

2. University Children's Hospital, Department of Hematology/Oncology, Tübingen, Germany

3. Boehringer Ingelheim Austria, Department of Exploratory Research, Research and Development, Vienna, Austria

4. University of Tübingen, Department of Internal Medicine IV, Division of Diabetes Research, Tübingen, Germany

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/stemcells.22-3-334

Reference26 articles.

1. Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34− cell preparations

2. Highly purified CD34-positive cells reconstitute hematopoiesis.

3. AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells

4. A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular Cloning

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression;Scientific Reports;2023-01-02

2. CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis;JCI Insight;2022-09-22

3. CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer;Life Sciences;2022-07

4. Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease;Aging;2022-02-16

5. CDCP1-targeted nanoparticles encapsulating phase-shift perfluorohexan for molecular US imaging in vitro;Clinical Hemorheology and Microcirculation;2022-01-29